(PharmaNewsWire.Com, February 07, 2018 ) The Latin America Intrauterine devices (IUD’S) Market was worth $ 238 million in 2016 and estimated to reach $ 301 million by the end of 2021 with a growing potential of 4.8 %.
Intrauterine devices (IUDs) are contraceptive medical implants used to avert pregnancies for a long time period. The intrauterine contraceptive device is a safe, effective and convenient contraceptive method. Their use in less developed countries has been controlled due to increase in menstrual blood loss, a vital issue in populations with a high prevalence of anaemia. The levonorgestrel releasing IUD (LNg IUD) which is the first device that is highly effective, long-lasting and reduces the blood loss during menstruation. So, this device is accepted, most used in Latin America. This device will have a clear niche amid reversible contraceptives when available.
Technical innovations, increasing prevalence of STD’S (Sexually transmitted diseases), direct health benefits other than birth control, increasing government initiatives to prevent unwanted abortions and pregnancies are driving the growth of the market in Latin America. The factors that are hampering the growth of the market are issues of Infertility, Religious and cultural opposition, ectopic pregnancy, pelvic inflammatory infection, and Limited access to contraception.
The Latin America intrauterine Devices market is broadly categorized based on product type into Hormonal intrauterine device and Copper intrauterine device. The largest share in the market is held by Hormonal IUD’S compared to Copper IUD’S due to their less risks and complications.
Key players influencing the Latin America intrauterine devices market are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer AG, Teva Pharmaceutical, Pfizer, Mylan laboratories, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc.
About Market Data Forecast: Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Contact: Name: Mr. Abhishek Shukla Email: abhishek@marketdataforecast.com Organization: MarketDataForecast™ Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India. Phone: +1-888-702-9626
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
